Fibroblast and prostate tumor cell cross-talk: fibroblast differentiation, TGF-β, and extracellular matrix down-regulation (Q45867047)

17 December 2017

title

Fibroblast and prostate tumor cell cross-talk: fibroblast differentiation, TGF-β, and extracellular matrix down-regulation (English)

1 reference

17 December 2017

0 references

1 reference

Vivien J Coulson-Thomas

1

1 reference

17 December 2017

Tarsis F Gesteira

2

1 reference

17 December 2017

Yvette M Coulson-Thomas

3

1 reference

17 December 2017

Carolina M Vicente

4

1 reference

17 December 2017

Ivarne L S Tersariol

5

1 reference

17 December 2017

Helena B Nader

6

1 reference

17 December 2017

Leny Toma

7

1 reference

17 December 2017

language of work or name

English

0 references

publication date

18 August 2010

1 reference

17 December 2017

Experimental Cell Research

published in

1 reference

17 December 2017

volume

316

1 reference

17 December 2017

issue

19

1 reference

17 December 2017

page(s)

3207-3226

1 reference

17 December 2017

Tumor-stromal interactions in bone metastasis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

Microenvironmental regulation of metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

Tumor microenvironment: Modulation by decorin and related molecules harboring leucine-rich tandem motifs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

The role of tumor microenvironment in prostate cancer bone metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

Proliferation of myofibroblasts in the stroma of epithelial hyperplastic lesions and squamous carcinoma of the larynx

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

New functions for the matrix metalloproteinases in cancer progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

Cysteine cathepsins: multifunctional enzymes in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

Cysteine cathepsins and the cutting edge of cancer invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

Urokinase-receptor (u-PAR): an essential player in multiple games of cancer: a review on its role in tumor progression, invasion, metastasis, proliferation/dormancy, clinical outcome and minimal residual disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

Heparanase: busy at the cell surface

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

Heparanase-2, syndecan-1, and extracellular matrix remodeling in colorectal carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

Hyaluronidases in cancer biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

Lumican and decorin are differentially expressed in human breast carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

De novo decorin gene expression suppresses the malignant phenotype in human colon cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

Ectopic expression of decorin protein core causes a generalized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-dependent kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

Biglycan is overexpressed in pancreatic cancer and induces G1-arrest in pancreatic cancer cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

Decorin binds near the C terminus of type I collagen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

Independent modulation of collagen fibrillogenesis by decorin and lumican

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

SLRP interaction can protect collagen fibrils from cleavage by collagenases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

Tensional homeostasis and the malignant phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

Collagen and Collagen-derived Fragments Are Chemotactic for Tumor Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

Cell adhesion and chemotaxis in prostate cancer metastasis to bone: a minireview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

Genetic deficiency of decorin causes intestinal tumor formation through disruption of intestinal cell maturation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

The small leucine-rich proteoglycan biglycan modulates BMP-4-induced osteoblast differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

WISP-1 binds to decorin and biglycan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

Binding of von Willebrand factor to the small proteoglycan decorin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

The potential functional interaction of biglycan and WISP-1 in controlling differentiation and proliferation of osteogenic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

Transient transgene expression of decorin in the lung reduces the fibrotic response to bleomycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

Different usage of the glycosaminoglycan attachment sites of biglycan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

Decorin inhibition of PDGF-stimulated vascular smooth muscle cell function: potential mechanism for inhibition of intimal hyperplasia after balloon angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

Biglycan isoforms with differences in polysaccharide substitution and core protein in human lung fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

TGF-beta signaling: positive and negative effects on tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

Transforming growth factor-beta signaling in prostate stromal cells supports prostate carcinoma growth by up-regulating stromal genes related to tissue remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

Transforming growth factor-beta1 modulates matrix metalloproteinase-9 production through the Ras/MAPK signaling pathway in transformed keratinocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

TGF-?-induced invasiveness of pancreatic cancer cells is mediated by matrix metalloproteinase-2 and the urokinase plasminogen activator system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

Transforming growth factor-beta induces CD44 cleavage that promotes migration of MDA-MB-435s cells through the up-regulation of membrane type 1-matrix metalloproteinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

Breast cancer cells induce stromal fibroblasts to express MMP-9 via secretion of TNF-alpha and TGF-beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

Stromagenesis: the changing face of fibroblastic microenvironments during tumor progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

Differential influence of normal and cancer-associated fibroblasts on the growth of human epithelial cells in an in vitro cocultivation model of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

Adult bone marrow-derived mononuclear cells expressing chondroitinase AC transplanted into CNS injury sites promote local brain chondroitin sulphate degradation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

The type III transforming growth factor-beta receptor as a novel tumor suppressor gene in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

Transforming growth factor-beta receptor III downregulation in prostate cancer: is inhibin B a tumor suppressor in prostate?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

7 January 2021

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

Down-regulation of protein and mRNA expression for transforming growth factor-beta (TGF-beta1) type I and type II receptors in human prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

Genetic changes in the transforming growth factor beta (TGF-beta) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

Autocrine transforming growth factor-beta 1 and beta 2 expression is increased by cell crowding and quiescence in colon carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

Loss of receptors for transforming growth factor beta in human T-cell malignancies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

The fibroblastic coconspirator in cancer progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

Immunohistochemical assessment of fibronectin and tenascin and their integrin receptors alpha5beta1 and alpha9beta1 in gastric and colorectal cancers with lymph node and liver metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

Vimentin affects the mobility and invasiveness of prostate cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

Vimentin filaments support extension of tubulin-based microtentacles in detached breast tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

Down-regulation of osteopontin suppresses growth and metastasis of hepatocellular carcinoma via induction of apoptosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

Rapid movements of vimentin on microtubule tracks: kinesin-dependent assembly of intermediate filament networks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

Detyrosinated microtubule protrusions in suspended mammary epithelial cells promote reattachment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: New findings and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

Matrix metalloproteinases: they're not just for matrix anymore!

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

Matrix metalloproteinase activity and osteoclasts in experimental prostate cancer bone metastasis tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

Loss of Bcl-2 expression in colon cancer: a prognostic factor for recurrence in stage II colon cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

Role of RANKL-induced osteoclast formation and MMP-dependent matrix degradation in bone destruction by breast cancer metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

Stromal regulation of epithelial function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.08.005

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YEXCR.2010.08.005

1 reference

17 December 2017

PubMed ID

20727350

1 reference

17 December 2017